Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

981studies shown

Showing 85-96 of 981

Behavioral study icon

RecruitingNCT06424184

Accelerated rTMS for Substance Use Disorder and Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

DepressionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Depression

Behavioral study icon

RecruitingNCT04982757

Accelerated TMS for Depression and OCD

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

DepressionBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: Weill Medical College of Cornell University
Condition: Depression

Device study icon

RecruitingNCT07147218

Accelerated TMS for MDD

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

DepressionDeviceOver 15 Years

Countries: United States
Sponsor: Neuronetics
Condition: Depression

Device study icon

RecruitingNCT06968390

Accelerated TMS for Perinatal Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

DepressionDeviceFrom 18 Years to 55 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Depression

Device study icon

RecruitingNCT06003036

Accelerated Transcranial Magnetic Stimulation for People With Schizophrenia Treated With Clozapine

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

In United States

SchizophreniaDeviceFrom 18 Years to 50 Years

Countries: United States
Sponsor: Deepak K. Sarpal, M.D.
Condition: Schizophrenia

Drug study icon

RecruitingNCT06706232

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolarity II Depression and Suicidality

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

In United States

Bipolarity, DepressionDrugFrom 25 Years to 70 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Bipolarity, Depression

Behavioral study icon

RecruitingNCT05491538

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

Depression, Schizophrenia, ...BehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression, Schizophrenia, ...

Behavioral study icon

RecruitingNCT05685368

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

This study is recruiting. It focuses on anxiety and currently lists participation information in the United States.

In United States

Anxiety, DepressionBehavioralFrom 14 Years to 21 Years

Countries: United States
Sponsor: Children's Hospital Los Angeles
Condition: Anxiety, Depression

Behavioral study icon

RecruitingNCT06647589

Acceptance and Commitment Therapy for Religious OCD

This study is recruiting. It focuses on mental health and currently lists participation information in the United States.

In United States

Mental healthBehavioralOver 18 Years

Countries: United States
Sponsor: University of Alabama at Birmingham
Condition: Mental health

Drug study icon

RecruitingNCT06408246

ACE-D Aim 3 Clinical Cognitive study to Enhance Translation in Depression

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

In United States

DepressionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression

Drug study icon

RecruitingNCT04887792

Acetazolamide for Treatment Resistant Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in India and the United States.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, India
Sponsor: Vishwajit Nimgaonkar, MD PhD
Condition: Schizophrenia

Drug study icon

RecruitingNCT06159673

ACP-204 in Adults With Alzheimer's Disease Psychosis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Brazil, Bulgaria, Chile, Czech Republic, France, Italy, Mexico, Serbia, South Korea, Spain, Taiwan, and the United States.

In United States

SchizophreniaDrugFrom 55 Years to 95 Years

Countries: United States, France, Brazil, ...
Sponsor: ACADIA Pharmaceuticals Inc.
Condition: Schizophrenia